Neuromod Devices announces it has secured a €200,000 investment from Enterprise Ireland and a further €650,000 from private investors to design and manufacture a stable clinical prototype and conduct pilot safety and feasibility studies into its new bimodal neuromodulation device for the treatment of tinnitus.
